Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study May 22, 2024 01:30PM
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study May 19, 2024 08:53PM
Virios Therapeutics (VIRI) Announces $2.1M Share Offering, Commences Preparations for Planned IMC-2 Long-COVID Phase 2b Study May 17, 2024 04:11PM
Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study May 17, 2024 04:10PM